<DOC>
	<DOCNO>NCT00002148</DOCNO>
	<brief_summary>To assess tolerability safety OPC-14117 . To evaluate effect OPC-14117 cognitive function , quality life , activity daily live .</brief_summary>
	<brief_title>Parallel Group , Placebo-Controlled , Tolerability , Safety , Efficacy Study OPC-14117 HIV Dementia</brief_title>
	<detailed_description>Patients receive OPC-14117 placebo bid 12 week , follow 12 week open label therapy .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Dementia</mesh_term>
	<mesh_term>Cognition Disorders</mesh_term>
	<mesh_term>AIDS Dementia Complex</mesh_term>
	<criteria>Inclusion Criteria Patients must : HIV seropositivity . Cognitive impairment . Prior Medication : Allowed : Prior OPC14117 current study . Antiretroviral therapy stable 6 week prior study entry ( 12 week stavudine ) . Exclusion Criteria Coexisting Condition : Patients follow symptoms condition exclude : Current opportunistic CNS infection ( i.e. , toxoplasmosis cryptococcal meningitis ) . Severe premorbid psychiatric illness include schizophrenia major depression would interfere protocol compliance . CNS neoplasms . Any clinically significant condition laboratory abnormality would interfere ability participate study . Current participation drug study . Patients follow prior condition exclude : Past history opportunistic CNS infection ( i.e. , toxoplasmosis cryptococcal meningitis ) . History chronic neurological disorder serious head injury , document stroke , multiple sclerosis , uncontrolled epilepsy , Tourette 's syndrome , neurodegenerative process Huntington 's disease . History adverse reaction / allergy OPC14117 . Prior participation study . Prior Medication : Excluded : Other investigational drug within past 30 day . Alcoholism within past 6 month ( 2 drink daily ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 1996</verification_date>
	<keyword>Cognition Disorders</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>AIDS-Related Complex</keyword>
	<keyword>Free Radical Scavengers</keyword>
	<keyword>Antioxidants</keyword>
	<keyword>OPC 14117</keyword>
</DOC>